PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021Business Wire • 08/23/21
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive ImpairmentsBusiness Wire • 08/17/21
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical OfficerBusiness Wire • 08/13/21
Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder ConditionBenzinga • 08/11/21
PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain SyndromeBusiness Wire • 08/11/21
PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHDBusiness Wire • 07/22/21
PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D FinancingBusiness Wire • 07/21/21
PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.Business Wire • 07/19/21
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)Business Wire • 07/09/21
PureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology on Qualcomm Snapdragon Mobile PlatformsBusiness Wire • 07/08/21
PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid TumorsBusiness Wire • 07/07/21
PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel DiseaseBusiness Wire • 06/30/21
Vedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inflammatory Bowel Disease, at the International Human Microbiome Consortium Congress 2021 (IHMC)Business Wire • 06/29/21
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly VolunteersBusiness Wire • 06/23/21
PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual MeetingBusiness Wire • 05/27/21
PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital TherapeuticsBusiness Wire • 05/26/21
PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung DisordersBusiness Wire • 05/12/21
Vedanta Biosciences to Present at the SVB Leerink Biopharma Private Company Connect EventBusiness Wire • 04/29/21
PureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer's Disease PathologiesBusiness Wire • 04/28/21